Form 4 for SONM DNA X, Inc.
Accepted 2021-10-15 00:00:00 ET · period of report 2021-10-08 · accession 0000899243-21-040377 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-15 | 2021-10-08 | SONM | MULICA MICHAEL C | Dir | A - Grant | $0.00 | +75.0K | 81.6K | +1,132% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-08 | A | A | 75,000 | $0.00 | 81,626 | D | — | — | (F1) Represents the grant of restricted stock units that vest in one installment on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. (F2) The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021. |